| Serial Number | 97775103 |
| Word Mark | WUXI TIDES |
| Filing Date | Tuesday, January 31, 2023 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Friday, August 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 12, 2024 |
| Goods and Services | Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Medicines for human purposes, namely, medicines for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Raw material medicine, namely, medicines for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Pharmaceutical preparations, for the treatment of cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders; pharmaceutical preparations, namely, antivirals; Chemico-pharmaceutical preparations for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Biological preparations for medical purposes for the treatment of cancer; Chemical preparations for the diagnosis of pregnancy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders healthcare and clinical applications; Chemical preparations for medical purposes, namely, chemical reagents for medical purposes; Chemical preparations for medical purposes for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Diagnostic preparations for medical purposes; Nutritional supplements; Drugs for medical purposes for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Reagent paper for medical purposes; Medical reagent; Disinfectants for hygiene purposes; Cultures of microorganisms for medical use; Biomedicines for the treatment of cancer, cardiovascular, hematologic, neurological,; gastrointestinal and genetic diseases; Adjuvants for medical purposes; Vaccines; Veterinary preparations for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases |
| NOT AVAILABLE | "WUXI" |
| Goods and Services | Computer programming; Material testing; Technical research in the field of pharmaceutical studies; Research and development of new products for others; Technology consultancy in the field of cybersecurity; Chemical analysis; Chemistry services, namely, chemistry consultation; Chemical research; Biological research; conducting clinical trials for others, being for scientific and medical research; Quality checking and testing, namely, quality control for others; Scientific laboratory services; Genome structure and function analysis; Gene screening, namely, DNA screening for scientific research purpose; Biomedical research services; Stem cell research service; Drug research and development services, namely, pharmaceutical research; cell culture services for scientific research purposes, for others; Design and development of computer hardware and software; Development and creation of computer programs for data processing; Computer programming in the field of medical treatment; Product quality testing; assessment of quality of products; Scientific research; Surveying; Bacteriological research; The design, production in the nature of design, or maintenance of a computer program; Computer software design; Computer technology consultancy in the field of engineering; Information technology consulting relating to computer network design; Artificial intelligence technology consulting; Research on artificial intelligence technology; Research and development of new products; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Drug evaluation, namely, pharmaceutical product evaluation; Vaccine research and development services; Cancer medicine research; Biotechnology research; Drug testing being testing of pharmaceuticals; Pharmaceutical research; Cancer scientific research for medical purposes; Development and Test of Chemical production methods; Implementing of early evaluation in the field of new drugs, namely, product quality testing; Biochemical research and analysis; Chemical analysis evaluation service; Chemical synthesis evaluation service; scientific research of the mode of action of chemical combinations on animals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, February 18, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, March 29, 2023 |
| First Use In Commerce Date | Monday, April 17, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, February 18, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, March 29, 2023 |
| First Use In Commerce Date | Monday, April 17, 2023 |
| Party Name | Shanghai SynTheAll Pharmaceutical Co., Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Shanghai 201500 CN |
| Party Name | Shanghai SynTheAll Pharmaceutical Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Shanghai 201500 CN |
| Event Date | Event Description |
| Saturday, February 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 3, 2023 | NEW APPLICATION ENTERED |
| Friday, February 3, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Friday, February 3, 2023 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Saturday, October 28, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, November 7, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 7, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 7, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 5, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, January 5, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, January 5, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, January 5, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, January 5, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, January 5, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, February 5, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 7, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, July 4, 2024 | USE AMENDMENT FILED |
| Wednesday, January 22, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, August 8, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, August 8, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, July 4, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, January 22, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 22, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, January 22, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |